Changes in angiotensin receptors expression play a pivotal role in the renal damage observed in spontaneously hypertensive rats

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 2, 2011, Pages

  Landgraf, Sharon S ^a   Wengert, Mira ^a   Silva, Jaqueline S ^a   Zapata Sudo, Gisele ^a   Sudo, Roberto T ^a   Takiya, Christina Maeda ^a   Pinheiro, Ana Acacia S ^a   Caruso Neves, Celso ^a  

^a FEDERAL UNIVERSITY OF RIO DE JANEIRO   (Brazil)

Author keywords

Angiotensin II receptors; Inflammation; Kidney; Renin angiotensin system

Indexed keywords

ANGIOTENSIN 1 RECEPTOR; ANGIOTENSIN 2 RECEPTOR; ANGIOTENSIN RECEPTOR; CYCLIC AMP DEPENDENT PROTEIN KINASE; HYDRALAZINE; LOSARTAN; PROTEIN KINASE C;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; GLOMERULUS; INFLAMMATION; KIDNEY CORTEX; KIDNEY FUNCTION; KIDNEY INJURY; MALE; MICROSOME; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; WISTAR KYOTO RAT;

EID: 79551550782     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00384.2010     Document Type: Article

References (35)

1. Aranoff DM, Canetti C, Serezani CH, Luo M, Peters-Golden M. Cutting edge: macrophage inhibition by cyclic AMP (cAMP): differential roles of protein kinase A and exchange protein directly activated by cAMP-1. J Immunol 74: 595-599, 2005.
2. Banday AA, Lokhandwala MF. Oxidative stress-induced renal angiotensin AT1 receptor upregulation causes increased stimulation of sodium transporters and hypertension. Am J Physiol Renal Physiol 295: F698-F706, 2008.
3. Baumann M, Hermans JJ, Janssen BJA, Peutz-Kooststra C, Witzke O, Heemann U, Smits FM, Boudier AJS. Transient prehypertensive treatment in spontaneously hypertensive rats: a comparison of spirolactone and losartan regarding long-term blood pressure and target organ damage. J Hypertens 25: 2504-2511, 2007.
4. Baumann M, Janssen BJ, Hermans JJ, Peutz-Kootstra C, Witzke O, Smits JF, Struijker Boudier HA. Transient AT1 receptor inhibition in prehypertensive spontaneously hypertensive rats results in maintained cardiac protection until advanced age. J Hypertens 25: 207-215, 2007.
5. Benndorf RA, Krebs C, Hirsch-Hoffmann B, Schwedhelm E, Cieslar G, Schmidt-Haupt R, Steinmetz OM, Meyer-Schwesinger C, Thaiss F, Haddad M, Fehr S, Heilmann A, Helmchan U, Hein L, Ehmke H, Stahl RA, Boger RH, Wenzel UO. Angiotensin II type 2 receptor deficiency aggravates renal injury and reduces survival in chronic kidney disease in mice. Kidney Int 75: 1039-1049, 2009.
6. Cao Z, Bonnet F, Candido R, Nesteroff SP, Burns WC, Kawachi H, Shimizu F, Carey RM, De Gasparo MC, Cooper ME. Angiotensin type 2 receptor antagonism confers renal protection in a rat model of progressive renal injury. J Am Soc Nephrol 13: 1773-1787, 2002.
7. Chrysohoou C, Pitsavos C, Panagiotakos DB, Skoumas J, Stefanadis C. Association between prehypertension status and inflammatory markers related to atherosclerotic disease. Am J Hypertens 17: 568-573, 2004.
8. Cogan MG. Angiotensin II: a powerful controller of sodium transport in the early proximal tubule. Hypertension 15: 451-458, 1990.
9. Cosentino F, Savoia C, Paolis PD, Francia P, Russo A, Maffei A, Venturelli V, Schiavoni Lembo G, Volpe M. Angiotensin II type 2 receptors contribute to vascular responses in spontaneously hypertensive rats treated with angiotensin II type I receptor antagonists. Am J Hypertens 18: 493-499, 2005.
10. Curtis JJ, Luke RG, Dustan HP, Kashgarian M, Whelchel JD, Jones P, Dielthem A. Remission of essential hypertension after renal transplantations. J Am Soc Nephrol 12: 2404-2412, 1983.
11. De Gasparo M, Catt HJ, Inagami T, Wright JW, Unger TH. International union of pharmacology. XXIII. The angiotensin II receptors. Pharmacol Rev 52: 415-472, 2000.
12. +-ATPase through AT2 receptor. Regul Pept 120: 167-175, 2004.
13. Green TP. Systemic vasodilatation and renal sodium excretion: effects of hydralazine and diazoxide. Life Sci 34: 2169-2176, 1984.
14. Grisk O, Retting R. Renal transplantation studies in genetic hypertension. News Physiol Sci 16: 262-265, 2001.
15. Hui-Fang C, Jun-Ling W, Gavin PV, Raymond CR. Young SHR express increased type I angiotensin II receptors in renal proximal tubule. Am J Physiol Renal Physiol 274: F10-F17, 1998.
16. 1 receptors regulate ACE2 and angiotensin-(1-7) expression in the aorta of spontaneously hypertensive rats. Am J Physiol Heart Circ Physiol 289: H1013-H1019, 2005.
17. Jameson M, Dai FX, Lüscher T, Skopec J, Diederich A, Diederich D. Endothelium-derived contracting factors in resistance arteries of young spontaneously hypertensive rats before development of overt hypertension. Hypertension 21: 280-288, 1993.
18. Julius S, Nesbitt Egan B, Kaciroti N, Schork A, Grozinski M, Michelson E. Trial of Preventing Hypertension design and 2-year progress report. Hypertension 44: 146-151, 2004.
19. Kline RL, McLennan GP. Chronic hydralazine treatment alters the acute pressure-natriuresis curve in young spontaneously hypertensive rats. Can J Physiol Pharmacol 69: 164-169, 1991.
20. Kobori H, Ozawa Y, Suzaki Y, Nishiyama A. Enhanced intrarenal angiotensinogen contributes to early renal injury in spontaneously hypertensive rats. J Am Soc Nephrol 16: 2073-2080, 2005.
21. Lopes de Faria JB, Zoukhrid D, Lorenzi M. Mesangial cell abnormalities in spontaneously hypertensive rats before the onset of hypertension. Kidney Int 52: 387-392, 1997.
22. Lowry OH, Rosebrough NJ, Farr AL, Randall RJ. Protein measurement with the Folin phenol reagent. J Biol Chem 193: 265-275, 1951.
23. Morgan T. Renin, angiotensin, sodium and organ damage. Hypertens Res 26: 349-354, 2003.
24. Moss MB, Rosene DL. A Perfusion-fixation procedure for the concurrent demonstration of Timm's, horseradish peroxidase (HRP), and acethycholinesterase (AchE) histochemistry. J Histochem Cytochem 32: 1113-1116, 1984.
25. Naito T, Ma LJ, Yang H, Zuo Y, Tang Y, Han JY, Kon V, Fogo AB. Angiotensin type 2 receptor actions contribute to angiotensin type 1 receptor blocker effects on kidney fibrosis. Am J Physiol Renal Physiol 298: F683-F691, 2010.
26. Naoko H, Maeshima Y, Satoh M, Odawara M, Sugiyama H, Kashihara N, Matsubara H, Yamasaki Y, Makino H. Overexpression of angiotensin type 2 receptor ameliorates glomerular injury in a mouse remnant kidney model. Am J Physiol Renal Physiol 286: F516-F525, 2004.
27. Norrelund H, Christensen KL, Samani NJ, Kimber P, Mulvany MI, Korsgaar D. Early narrowed afferent arteriole is a contributor to the development of hypertension. Hypertension 24: 301-308, 1994.
28. Preiss S, Namgaladze D, Brüne B. Critical role for classical PKC in activating Akt by phospholipase A2-modified LDL in monocytic cells. Cardiovasc Res 73: 833-840, 2007.
29. +-ATPase in spontaneous hypertensive rats: possible AT(1) receptor target in the development of hypertension. Biochim Biophys Acta 1798: 360-366, 2010.
30. +-ATPase activity through the activation of protein kinase C. Biochim Biophys Acta 1564: 310-316, 2002.
31. Tanabe A, Naruse M, Hara Y, Sato A, Tsuchiya K, Nishikawa T, Imaki T, Takano K. Aldosterone antagonist facilitates the cardioprotective effects of angiotensin receptor blockers in hypertensive rats. J Hypertens 22: 1017-1023, 2004.
32. Uyehara CF, Gellai M. Impairment of renal function precedes establishment of hypertension in spontaneously hypertensive rats. Am J Physiol Regul Integr Comp Physiol 265: R943-R950, 1993.
33. Vieyra A, Nachbin L, de Dios-Abad E, GoldFeld M, Meyer-Fernandes JR, Moraes L. Comparison between calcium transport and adenosine triphosphatase activity in membrane vesicles derived from rabbit kidney proximal tubules. J Biol Chem 261: 4347-4355, 1986.
34. 2 receptors. Kidney Int 61: 1986-1995, 2002.
35. You D, Loufrani L, Baron C, Levy BL, Widdop RE, Henrion D. High blood pressure reduction reverses angiotensin II type 2 receptor-mediated vasoconstriction into vasodilation in spontaneously hypertensive rats. Circulation 111: 1006-1011, 2005.